4.8 Article

The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress

Journal

ELIFE
Volume 3, Issue -, Pages -

Publisher

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.03077

Keywords

-

Categories

Funding

  1. National Cancer Institute [CA 172468-02, CA0954412-12, CA127724-05, CA129828-04]

Ask authors/readers for more resources

The 'ribosomal stress (RS)-p53 pathway' is triggered by any stressor or genetic alteration that disrupts ribosomal biogenesis, and mediated by several ribosomal proteins (RPs), such as RPL11 and RPL5, which inhibit MDM2 and activate p53. Inosine monophosphate (IMP) dehydrogenase 2 (IMPDH2) is a rate-limiting enzyme in de novo guanine nucleotide biosynthesis and crucial for maintaining cellular guanine deoxy- and ribonucleotide pools needed for DNA and RNA synthesis. It is highly expressed in many malignancies. We previously showed that inhibition of IMPDH2 leads to p53 activation by causing RS. Surprisingly, our current study reveals that Inauzhin (INZ), a novel non-genotoxic p53 activator by inhibiting SIRT1, can also inhibit cellular IMPDH2 activity, and reduce the levels of cellular GTP and GTP-binding nucleostemin that is essential for rRNA processing. Consequently, INZ induces RS and the RPL11/RPL5-MDM2 interaction, activating p53. These results support the new notion that INZ suppresses cancer cell growth by dually targeting SIRT1 and IMPDH2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

BCL7C suppresses ovarian cancer growth by inactivating mutant p53

Canhua Huang, Qian Hao, Getao Shi, Xiang Zhou, Yu Zhang

Summary: BCL7C plays a tumor-suppressive role in ovarian cancer by inhibiting mutant p53 activity, leading to decreased cell proliferation and invasion in cancer cells. Low levels of BCL7C are associated with poor prognosis in ovarian cancer, suggesting its potential as a therapeutic target.

JOURNAL OF MOLECULAR CELL BIOLOGY (2021)

Article Cell Biology

p53 induces ARTS to promote mitochondrial apoptosis

Qian Hao, Jiaxiang Chen, Junming Liao, Yingdan Huang, Yu Gan, Sarit Larisch, Shelya X. Zeng, Hua Lu, Xiang Zhou

Summary: ARTS and p53 collaborate closely in mitochondria-engaged apoptosis, with ARTS inducing apoptosis by antagonizing anti-apoptotic proteins and p53 activating the expression of ARTS.

CELL DEATH & DISEASE (2021)

Article Cell Biology

LncRNA RNA Component of Mitochondrial RNA-Processing Endoribonuclease Promotes AKT-Dependent Breast Cancer Growth and Migration by Trapping MicroRNA-206

Yingdan Huang, Bangxiang Xie, Mingming Cao, Hua Lu, Xiaohua Wu, Qian Hao, Xiang Zhou

Summary: The RNA component RMRP is highly expressed in various malignant cancers and associated with poor prognosis. It indirectly elevates AKT expression and promotes breast cancer progression, with AKT knockdown abolishing RMRP-induced cancer cell growth and migration.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma

Qian Hao, Jiajia Li, Qinghua Zhang, Fei Xu, Bangxiang Xie, Hua Lu, Xiaohua Wu, Xiang Zhou

Summary: This study using single-cell transcriptomics analysis of HGSOC samples reveals new molecular features and potential therapeutic targets, which could advance the understanding and treatment of the disease.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Editorial Material Oncology

The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy

Qian Hao, Xiang Zhou

CANCER BIOLOGY & MEDICINE (2022)

Article Oncology

Olaparib Induces RPL5/RPL11-Dependent p53 Activation via Nucleolar Stress

Tao Han, Jing Tong, Mengxin Wang, Yu Gan, Bo Gao, Jiaxiang Chen, Youxun Liu, Qian Hao, Xiang Zhou

Summary: Olaparib is a widely used PARP inhibitor in the treatment of solid tumors. Its anti-tumor activity is achieved through the inhibition of PARP enzymes and blocking DNA repair. This study reveals that Olaparib activates the nucleolar stress-RPs-p53 pathway, leading to the activation of p53 and the inhibition of cancer cell survival and proliferation.

FRONTIERS IN ONCOLOGY (2022)

Editorial Material Cell Biology

Editorial: The expanding network of p53 signaling: Reaching to the unknown of cancer

Xiang Zhou, Ji Hoon Jung, Hua Lu

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Cell Biology

The ARTS of p53-dependent mitochondrial apoptosis

Qian Hao, Jiaxiang Chen, Hua Lu, Xiang Zhou

Summary: The tumor-suppressive activity of p53 is mainly due to its ability to induce cell death, specifically apoptosis, through various mechanisms. It transcriptionally activates pro-apoptotic genes and inhibits anti-apoptotic genes, leading to mitochondrial apoptosis. It also promotes mitochondrial apoptosis by directly interacting with BCL-2 family proteins in the mitochondria. ARTS, a pro-apoptotic protein encoded by an alternative spliced variant of the SEPT4 gene, facilitates BCL-2 and XIAP degradation, triggering apoptosis. ARTS is a new p53 target gene that enhances mitochondrial apoptosis by interacting with p53. This review discusses the mechanisms of p53-induced mitochondrial apoptosis, the role of ARTS in regulating mitochondrial cell death, and the clinical significance of ARTS in cancer and non-cancer diseases.

JOURNAL OF MOLECULAR CELL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Cuproptosis: p53-regulated metabolic cell death?

Chen Xiong, Hong Ling, Qian Hao, Xiang Zhou

Summary: Cuproptosis is a newly identified form of copper-induced cell death that primarily affects cells relying on oxidative phosphorylation as their main energy source. This process involves copper binding to lipoylated proteins in the tricarboxylic acid cycle, leading to the aggregation of these proteins, destabilization of iron-sulfur cluster proteins, and proteotoxic stress. Cancer cells, on the other hand, predominantly utilize glycolysis and are resistant to cuproptosis. However, the tumor suppressor p53, which regulates metabolism, may have a role in cuproptosis regulation by influencing glycolysis and the biogenesis of iron-sulfur clusters and the copper chelator glutathione.

CELL DEATH AND DIFFERENTIATION (2023)

Review Cell Biology

Regulation of the tumor immune microenvironment by cancer-derived circular RNAs

Liping Guan, Qian Hao, Fenfen Shi, Bo Gao, Mengxin Wang, Xiang Zhou, Tao Han, Wenjie Ren

Summary: Circular RNA (circRNAs) is a circular non-coding RNA formed by back-splicing from precursor messenger RNA. It can be released and captured by other cell types, acting as connections between different cell types for signaling pathways. CircRNAs reshape the tumor microenvironment (TME) by regulating epithelial-stromal transformation, tumor vascularization, immune cell function, and inflammatory responses, playing a crucial role in cancer development.

CELL DEATH & DISEASE (2023)

Article Biochemistry & Molecular Biology

UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosis

Yu Gan, Jun Deng, Qian Hao, Yingdan Huang, Tao Han, Jin-Guo Xu, Min Zhao, Litong Yao, Yingying Xu, Jianping Xiong, Hua Lu, Chunmeng Wang, Jiaxiang Chen, Xiang Zhou

Summary: In this study, it was found that UTP11 plays a crucial role in the biosynthesis of 18S ribosomal RNAs (rRNA) by binding to the pre-rRNA processing factor, MPP10. UTP11 is overexpressed in human cancers and is associated with poor prognoses. Depletion of UTP11 inhibits cancer cell growth through p53-dependent and -independent mechanisms, while UTP11 overexpression promotes cancer cell growth and progression. The study also reveals that UTP11 depletion triggers nucleolar stress and enhances ferroptosis, contributing to the inhibition of cancer cell survival and growth.

REDOX BIOLOGY (2023)

Article Biochemistry & Molecular Biology

KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer

Litong Yao, Qian Hao, Mozhi Wang, Yuhai Chen, Hongyi Cao, Qiang Zhang, Keda Yu, Yizhou Jiang, Zhiming Shao, Xiang Zhou, Yingying Xu

Summary: In this study, researchers identified KLHL29 as a crucial tumor suppressor that regulates chemosensitivity in triple-negative breast cancer (TNBC). Low levels of KLHL29 were associated with unfavorable prognoses. Mechanistically, KLHL29 suppressed TNBC growth by degrading DDX3X and inhibiting cell cycle progression. The combination of DDX3X inhibitor RK33 and platinum-based chemotherapy showed promising results in suppressing TNBC.

ONCOGENE (2023)

Letter Biology

Nucleolar stress promotes and cooperates with ferroptosis to suppress cancer growth

Hanzhi Dong, Quan Liao, Bangxiang Xie, Yu-an Qiu, Zhiqiang Peng, Jun Deng, Jianping Xiong, Hua Lu, Qian Hao, Xiang Zhou

SCIENCE CHINA-LIFE SCIENCES (2023)

Article Medicine, General & Internal

Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma

Bangxiang Xie, Qian Hao, Xiang Zhou, Dexi Chen

Summary: The HBx protein of hepatitis B virus interacts with the TAp63 protein and inhibits its transcriptional activity, leading to the progression of hepatocellular carcinoma with defective p53.

CHINESE MEDICAL JOURNAL (2022)

Article Medicine, Research & Experimental

Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation

Hanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, Lu Zhang, Tao Yu, Yifan Sun, Yujing Li, Changlin Wan, Ka Man So, Degang Liu, Michael Frieden, Yuanzhang Fang, Amber L. Mosley, Xiaoming He, Xinna Zhang, George E. Sandusky, Yunlong Liu, Samy O. Meroueh, Chi Zhang, Aruna B. Wijeratne, Cheng Huang, Guang Ji, Xiongbin Lu

Summary: The compound atractylenolide I (ATT-I) has been found to enhance tumor antigen presentation and boost the cytotoxic response of CD8(+) T cells by targeting the function of the immunoproteasome, ultimately improving the tumor response to immunotherapy.

JOURNAL OF CLINICAL INVESTIGATION (2021)

No Data Available